Blueprint Medicines's market cap is currently $5.91B. The company's EPS TTM is $-1.071; its P/E ratio is ―; Blueprint Medicines is scheduled to report earnings on February 13, 2025, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	$ 508.82M	$ 249.38M	$ 204.04M	$ 180.08M	$ 793.74M
Gross Profit	$ 488.66M	$ 236.58M	$ 186.22M	$ 162.15M	$ 793.31M
Operating Income	$ -212.04M	$ -486.28M	$ -549.25M	$ -648.46M	$ 302.15M
EBITDA	$ -212.04M	$ -470.36M	$ -515.41M	$ -628.30M	$ 308.71M
Net Income	$ -67.09M	$ -506.98M	$ -557.52M	$ -644.09M	$ 313.88M
Balance Sheet
Cash & Short-Term Investments	$ 615.49M	$ 710.64M	$ 1.08B	$ 1.03B	$ 1.55B
Total Assets	$ 1.18B	$ 1.05B	$ 1.35B	$ 1.25B	$ 1.72B
Total Debt	$ 126.05M	$ 774.12M	$ 242.45M	$ 111.41M	$ 89.60M
Net Debt	$ 24.04M	$ 702.84M	$ 122.74M	$ -98.54M	$ -595.03M
Total Liabilities	$ 881.15M	$ 918.64M	$ 835.23M	$ 281.49M	$ 248.31M
Stockholders' Equity	$ 298.67M	$ 130.61M	$ 514.68M	$ 970.74M	$ 1.47B
Cash Flow
Free Cash Flow	$ -197.22M	$ -452.91M	$ -511.20M	$ -559.89M	$ 383.88M
Operating Cash Flow	$ -192.59M	$ -436.85M	$ -502.28M	$ -298.65M	$ 387.04M
Investing Cash Flow	$ -47.50M	$ 274.04M	$ -149.54M	$ -225.86M	$ -434.25M
Financing Cash Flow	$ 273.11M	$ 119.22M	$ 561.81M	$ 50.72M	$ 617.76M

Currency in USD

Blueprint Medicines Earnings and Revenue History

Income Statement >

Blueprint Medicines Debt to Assets

Balance Sheet >

Blueprint Medicines Cash Flow

Cash Flow >

Blueprint Medicines Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing